BRAIN and NERVE Shinkei Kenkyu no Shinpo Volume 71, Issue 5 (May 2019)
Japanese

Progressive Multifocal Leukoencephalopathy in Systemic Lupus Erythematosus Motohiro Yukitake 1,2 1Neurology, Kouhoukai Takagi Hospital 2International University of Health and Welfare (IUHW) Keyword: 進行性多巣性白質脳症 , 全身性エリテマトーデス , 病態修飾療法 , ベリムマブ , リツキシマブ , progressive multifocal leukoencephalopathy , systemic lupus erythematosus , disease modifying therapy , belimumab , rituximab pp.493-505
Published Date 2019/5/1
DOI https://doi.org/10.11477/mf.1416201301
  • Abstract
  • Look Inside
  • Reference

Abstract

Here, progressive multifocal leukoencephalopathy (PML) and PML in systemic lupus erythematosus (SLE) are reviewed. Disease-modifying therapy (DMT) associated PML is an emerging condition, particularly in multiple sclerosis patients. Although PML is a rare adverse event in SLE, we should consider development of PML more carefully in not only conventional drug-induced PML but also DMT associated PML during SLE treatment in the era of DMT associated PML.


Copyright © 2019, Igaku-Shoin Ltd. All rights reserved.

基本情報

18816096.71.5.jpg
BRAIN and NERVE-神経研究の進歩
71巻5号 (2019年5月)
電子版ISSN 1344-8129 印刷版ISSN 1881-6096 医学書院

関連文献

もっと見る

文献を共有